BID Preferentially Activates BAK while BIM Preferentially Activates BAX, Affecting Chemotherapy Response-Reference-Cited by-同舟云学术

BID Preferentially Activates BAK while BIM Preferentially Activates BAX, Affecting Chemotherapy Response

Published:2013-09 Issue:6 Volume:51 Page:751-765
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Sarosiek Kristopher A.,Chi Xiaoke,Bachman John A.,Sims Joshua J.,Montero Joan,Patel Luv,Flanagan Annabelle,Andrews David W.,Sorger Peter,Letai Anthony

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference60 articles.

1. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver;Adachi;Nat. Genet.,1995

2. Etoposide, topoisomerase II and cancer;Baldwin;Curr. Med. Chem. Anticancer Agents,2005

3. Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation;Biswas;J. Biol. Chem.,2002

4. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization;Bossy-Wetzel;EMBO J.,1998

5. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity;Bouillet;Science,1999

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiling protein–protein interactions to predict the efficacy of B-cell-lymphoma-2-homology-3 mimetics for acute myeloid leukaemia;Nature Biomedical Engineering;2024-07-18

2. Sorcin Inhibits Mitochondrial Apoptosis by Interacting with STAT3 via NF-κB Pathway;International Journal of Molecular Sciences;2024-06-29

3. Discovery of Phenylpyrazole Derivatives as a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity;ACS Omega;2024-06-13

4. Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics;Science Translational Medicine;2024-06-05

5. Dysregulation of BCL-2 family proteins in blood neoplasm: therapeutic relevance of antineoplastic agent venetoclax;Exploration of Medicine;2024-05-10